![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
X
01 ACTELION REGISTRATION LTD (2)
02 Campus pharma AB (2)
03 GlaxoSmithKline AG (1)
04 GlaxoSmithKline leads AS (2)
05 NTC Srl (2)
06 WELLCOME FOUNDATION LTD (1)
01 Epoprostenol Sodium (10)
01 Italy (5)
02 Norway (4)
03 Switzerland (1)
01 Epoprostenol 0.5Mg 1 Unit Parenteral Use (2)
02 Epoprostenol 1,5Mg 1 Unit Parenteral Use (3)
03 Powder and liquid to the infusion fluid, resolution (4)
04 Solution (1)